Headquartered in Hallbergmoos near Munich, Germany, HEKUMA is Europe’s leading provider of sophisticated turnkey solutions for high-performance automation of the manufacturing of injection molded and thermoformed plastic products. HEKUMA focuses on medical applications, including disposable labware, diagnostics and medication. In addition, HEKUMA serves the automotive sector (i.e., e-mobility solutions) and personal care products (e.g., razors or electric toothbrushes). Demonstrated by a track record of more than 5,000 installed systems globally, HEKUMA’s systems are characterized as having the highest availability, largest cavity numbers, shortest process and integrated quality inspection times. HEKUMA’s cavity-oriented packaging and defect parts discharge functions lead the industry.
Publicly listed Dürr (XTRA: DUE) combines world-leading expertise in mechanical and plant engineering with extensive solutions in digitalization / Industry 4.0. Earlier in 2021, Dürr acquired a majority stake in an automation specialist, Teamtechnik, forming a platform for the targeted growth in the medical sector. HEKUMA will perfectly complement this existing solution offering and will benefit from synergies along the value chain as well as improved customer access, particularly in the large markets in China and North America.
Lincoln International acted as the exclusive sell-side advisor to elexis and HEKUMA, working closely with the management team and shareholders throughout the sale process. This included providing advisory expertise and managing the marketing, negotiation and due diligence phases of the transaction. The terms of the transaction were not disclosed.